After they lose patent rights on certain medicines , some drug manufacturers are striking deals that allow insurers and pharmaceutical benefit managers to choose their brand - name products over others — potentially at the expense of patients .
After they lose patent protection on certain medicines, some drug companies are striking deals that encourage insurers and pharmacy benefit managers to favor their brand-name products over generics—potentially at the expense of patients.